Compassionate Use of Metvix [Methyl aminolevulinate] PDT [photodynamic therapy] in Subjects With Field Actinic Keratoses, Large/Multiple Superficial BCCs [basal cell cancer], or Bowen's Disease

Trial Profile

Compassionate Use of Metvix [Methyl aminolevulinate] PDT [photodynamic therapy] in Subjects With Field Actinic Keratoses, Large/Multiple Superficial BCCs [basal cell cancer], or Bowen's Disease

Recruiting
Phase of Trial: Phase III

Latest Information Update: 30 Oct 2009

At a glance

  • Drugs Methyl aminolevulinate (Primary)
  • Indications Actinic keratosis; Basal cell cancer; Bowen's disease; Skin cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Galderma
  • Most Recent Events

    • 01 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top